查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
色胺 API 全球市場 - 全球產業分析、規模、份額、成長、趨勢、預測 (2031) - 按等級、按原料、按應用、按地區
市場調查報告書
商品編碼
1397319

色胺 API 全球市場 - 全球產業分析、規模、份額、成長、趨勢、預測 (2031) - 按等級、按原料、按應用、按地區

Tryptamines API Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
出版日期: | 出版商: Fairfield Market Research | 英文 289 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

全球色胺 API（活性藥物成分）市場規模經歷了顯著增長，預計 2024 年收入將達到 6.3 億美元。 該市場持續快速擴張，預計到2031年底估值將達到1.65兆美元。

色胺原料藥市場是由多種因素驅動的，包括偏頭痛疾病盛行率的上升、色胺潛在的抗癌作用，以及色胺在神經和精神疾病治療中的探索。我正在實現它。 對特種藥物的需求促進了色胺 API 市場的成長，尤其是在北美，因為色胺 API 越來越多地用於治療偏頭痛和其他神經系統疾病。

偏頭痛是最常見的神經系統疾病之一，每年影響超過 10 億人。 偏頭痛發展的複雜性，加上各種社會和生物風險因素，刺激了對有效治療的需求，推動了色胺原料藥市場的發展。 由於認識到其治療潛力，對包括色胺迷幻劑在內的精神活性化學物質的神經效應的研究增加。 色胺用於治療各種神經和精神疾病的探索預計將推動市場成長。

本報告調查了全球色胺原料藥市場，並提供了市場概況，包括按等級、原材料、應用、地區劃分的趨勢以及進入市場的公司的競爭趨勢。

目錄

第 1 章執行摘要

第二章市場概述

  • 市場定義與細分
  • 市場動態
  • 價值鏈分析
  • 波特五力分析
  • 新冠肺炎 (COVID-19) 影響分析
  • 烏克蘭和俄羅斯之間衝突的影響
  • 經濟概況
  • 杵分析

第三章2018-2023年生產與貿易統計

第 4 章價格分析，2018-2023

第 5 章2018-2031 年全球色胺 API 市場展望

  • 2018-2031 年全球色胺 API 市場前景（依等級、價值（十億美元）、數量（公斤））
  • 2018-2031 年全球色胺 API 市場前景（依原料、價值（十億美元）、數量（公斤））
  • 2018-2031 年全球色胺 API 市場前景（按應用分類）、價值（十億美元）、數量（公斤）
  • 2018-2031 年全球色胺 API 市場展望，以地區、價值（美元）、數量（公斤）

第 6 章北美色胺 API 市場展望，2018-2031

第 7 章歐洲色胺 API 市場前景，2018-2031

第 8 章亞太地區色胺 API 市場展望，2018-2031

第 9 章拉丁美洲色胺 API 市場展望，2018-2031

第10章中東與非洲色胺原料藥市場前景，2018-2031

第十一章競爭態勢

  • 最終用戶和原料的熱圖
  • 按製造商和原料劃分的熱圖
  • 2023 年公司市佔率分析
  • 競爭力儀表板
  • 公司簡介
    • Merck
    • Avra Synthesis Private Limited
    • Spectrum Chemical
    • Cayman Chemical Company (Matreya)
    • Tokyo Chemical Industry Co. Ltd.
    • Santa Cruz Biotechnology, Inc.
    • LGC Standards
    • Avra Synthesis Private Limited
    • SimSon Pharma Limited
    • Glentham Life

第12章附錄

簡介目錄

The Global Tryptamines API (Active Pharmaceutical Ingredient) Market has witnessed substantial growth, recording revenue of US$ 630 million in 2024. The market is projected to continue its rapid expansion, aiming to reach a valuation of US$ 1650 billion by the end of 2031, according to a recent report released by Fairfield Market Research.

Key Market Highlights:

  • Tryptamines and Their Significance: Tryptamines are monoamine alkaloids found in mammals, fungi, and plants, with structural similarities to the amino acid tryptophan. They serve as the foundation for various biologically active substances, including psychedelic drugs and neurotransmitters.
  • Market Growth Drivers: The market for Tryptamines APIs is experiencing growth due to several factors, including the rising prevalence of migraine disorders, the potential anti-cancer effects of tryptamine, and the exploration of tryptamines for therapeutic use in neurological and psychiatric conditions.
  • Demand for Specialized Pharmaceuticals: The need for specialized pharmaceuticals, particularly in North America, has contributed to the growth of the Tryptamines API market, as these APIs are increasingly utilized in the treatment of migraine and other neurological conditions.

Factors Fueling Market Growth:

  • Prevalence of Migraine Disorders: Migraine is one of the most common neurological disorders, affecting over one billion people annually. The complexity of migraine development, along with various social and biological risk factors, has led to an increased demand for effective treatments, driving the market for Tryptamines APIs.
  • Psychoactive Chemicals and Therapeutic Potential: Research into the neurological effects of psychoactive chemicals, including tryptamine psychedelics, has grown due to their perceived therapeutic potential. The exploration of tryptamines for treating various neurological and psychiatric conditions is expected to fuel market growth.

Challenges Affecting Market Growth:

  • High Capital Investment: The manufacturing of Tryptamines APIs involves significant capital investment due to various factors, including infrastructure, equipment, and quality standards. These high capital requirements may hinder market growth.

Key Market Dynamics:

  • United States Market Surge: North America, particularly the United States, is expected to dominate the Tryptamines API market due to the region's increasing demand for specialized pharmaceuticals and the high prevalence of migraine disorders.
  • Germany's Lucrative Market: Germany offers numerous advantages for Tryptamines API manufacturers, including investments in R&D projects and the presence of significant regional market participants.
  • China's Growing Market: China is becoming a prominent market for Tryptamines APIs, with Chinese API producers obtaining globally recognized Good Manufacturing Practice (GMP) accreditation.

Highly Sought-after API Grade: GMP-grade Tryptamines APIs, produced in compliance with established quality standards for clinical use, are in high demand.

Preferred Source of Tryptamines APIs: Synthetic chemical APIs, known as small molecules, are widely used in the pharmaceutical industry. They include medications like sumatriptan, ondansetron, and alosetron.

Competitive Landscape:

Major market players are focusing on expansion strategies to tap into potential markets, emphasizing the mass production of GMP-compliant products with market potential in underdeveloped regions.

Key Companies in the Market:

  • Merck
  • Spectrum Chemical
  • LGC Standards
  • Cayman Chemical Company (Matreya)
  • Psygen
  • Biosynth
  • Clearsynth Labs
  • Glentham Life
  • Pharmaffiliates Analytics and Synthetics P. Ltd.
  • Santa Cruz Biotechnology, Inc.
  • SimSon Pharma Limited
  • Otto Chemie Pvt. Ltd
  • Tokyo Chemical Industry Co. Ltd.
  • Avra Synthesis Private Limited

Market Segmentation

Grade:

  • GMP Grade
  • Non-GMP Grade

Source:

  • Natural
  • Synthetic
  • Bio-Synthetic

Application:

  • Clinical Use
  • Research Use

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Tryptamines API Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Production Output and Trade Statistics, 2018 - 2023

  • 3.1. Global Tryptamines API Market Production Output, by Region, Value (US$ Bn) and Volume (in Kgs), 2018 - 2023
    • 3.1.1. North America
    • 3.1.2. Europe
    • 3.1.3. Asia Pacific
    • 3.1.4. Latin America
    • 3.1.5. Middle East and Africa

4. Price Analysis, 2018 - 2023

  • 4.1. Global Average Price Analysis, by Grade/ Material, US$ Per Unit, 2018 - 2023
  • 4.2. Prominent Factor Affecting Peripheral Stent Implants Prices
  • 4.3. Global Average Price Analysis, by Region, US$ Per Unit

5. Global Tryptamines API Market Outlook, 2018 - 2031

  • 5.1. Global Tryptamines API Market Outlook, by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. GMP Grade
      • 5.1.1.2. Non-GMP Grade
  • 5.2. Global Tryptamines API Market Outlook, by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Natural
      • 5.2.1.2. Synthetic
      • 5.2.1.3. Bio-Synthetic
  • 5.3. Global Tryptamines API Market Outlook, by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Clinical Use
      • 5.3.1.2. Research Use
  • 5.4. Global Tryptamines API Market Outlook, by Region, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. North America
      • 5.4.1.2. Europe
      • 5.4.1.3. Asia Pacific
      • 5.4.1.4. Latin America
      • 5.4.1.5. Middle East & Africa

6. North America Tryptamines API Market Outlook, 2018 - 2031

  • 6.1. North America Tryptamines API Market Outlook, by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. GMP Grade
      • 6.1.1.2. Non-GMP Grade
  • 6.2. North America Tryptamines API Market Outlook, by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Natural
      • 6.2.1.2. Synthetic
      • 6.2.1.3. Bio-Synthetic
  • 6.3. North America Tryptamines API Market Outlook, by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Clinical Use
      • 6.3.1.2. Research Use
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. North America Tryptamines API Market Outlook, by Country, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. U.S. Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 6.4.1.2. U.S. Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 6.4.1.3. U.S. Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 6.4.1.4. Canada Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 6.4.1.5. Canada Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 6.4.1.6. Canada Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Europe Tryptamines API Market Outlook, 2018 - 2031

  • 7.1. Europe Tryptamines API Market Outlook, by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. GMP Grade
      • 7.1.1.2. Non-GMP Grade
  • 7.2. Europe Tryptamines API Market Outlook, by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Natural
      • 7.2.1.2. Synthetic
      • 7.2.1.3. Bio-Synthetic
  • 7.3. Europe Tryptamines API Market Outlook, by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Clinical Use
      • 7.3.1.2. Research Use
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Europe Tryptamines API Market Outlook, by Country, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Germany Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.2. Germany Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.3. Germany Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.4. U.K. Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.5. U.K. Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.6. U.K. Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.7. France Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.8. France Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.9. France Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.10. Italy Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.11. Italy Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.12. Italy Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.13. Turkey Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.14. Turkey Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.15. Turkey Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.16. Russia Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.17. Russia Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.18. Russia Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.19. Rest of Europe Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.20. Rest of Europe Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.21. Rest of Europe Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Asia Pacific Tryptamines API Market Outlook, 2018 - 2031

  • 8.1. Asia Pacific Tryptamines API Market Outlook, by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. GMP Grade
      • 8.1.1.2. Non-GMP Grade
  • 8.2. Asia Pacific Tryptamines API Market Outlook, by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Natural
      • 8.2.1.2. Synthetic
      • 8.2.1.3. Bio-Synthetic
  • 8.3. Asia Pacific Tryptamines API Market Outlook, by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Clinical Use
      • 8.3.1.2. Research Use
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Asia Pacific Tryptamines API Market Outlook, by Country, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. China Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.2. China Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.3. China Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.4. Japan Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.5. Japan Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.6. Japan Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.7. South Korea Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.8. South Korea Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.9. South Korea Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.10. India Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.11. India Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.12. India Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.13. Southeast Asia Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.14. Southeast Asia Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.15. Southeast Asia Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.16. Rest of Asia Pacific Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.17. Rest of Asia Pacific Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.18. Rest of Asia Pacific Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Latin America Tryptamines API Market Outlook, 2018 - 2031

  • 9.1. Latin America Tryptamines API Market Outlook, by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 9.1.1. Key Highlights
      • 9.1.1.1. GMP Grade
      • 9.1.1.2. Non-GMP Grade
  • 9.2. Latin America Tryptamines API Market Outlook, by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 9.2.1.1. Natural
    • 9.2.1.2. Synthetic
    • 9.2.1.3. Bio-Synthetic
  • 9.3. Latin America Tryptamines API Market Outlook, by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 9.3.1. Key Highlights
      • 9.3.1.1. Clinical Use
      • 9.3.1.2. Research Use
    • 9.3.2. BPS Analysis/Market Attractiveness Analysis
  • 9.4. Latin America Tryptamines API Market Outlook, by Country, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 9.4.1. Key Highlights
      • 9.4.1.1. Brazil Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 9.4.1.2. Brazil Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 9.4.1.3. Brazil Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 9.4.1.4. Mexico Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 9.4.1.5. Mexico Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 9.4.1.6. Mexico Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 9.4.1.7. Argentina Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 9.4.1.8. Argentina Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 9.4.1.9. Argentina Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 9.4.1.10. Rest of Latin America Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 9.4.1.11. Rest of Latin America Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 9.4.1.12. Rest of Latin America Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 9.4.2. BPS Analysis/Market Attractiveness Analysis

10. Middle East & Africa Tryptamines API Market Outlook, 2018 - 2031

  • 10.1. Middle East & Africa Tryptamines API Market Outlook, by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 10.1.1. Key Highlights
      • 10.1.1.1. GMP Grade
      • 10.1.1.2. Non-GMP Grade
  • 10.2. Middle East & Africa Tryptamines API Market Outlook, by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 10.2.1. Key Highlights
      • 10.2.1.1. Natural
      • 10.2.1.2. Synthetic
      • 10.2.1.3. Bio-Synthetic
  • 10.3. Middle East & Africa Tryptamines API Market Outlook, by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 10.3.1. Key Highlights
      • 10.3.1.1. Clinical Use
      • 10.3.1.2. Research Use
    • 10.3.2. BPS Analysis/Market Attractiveness Analysis
  • 10.4. Middle East & Africa Tryptamines API Market Outlook, by Country, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 10.4.1. Key Highlights
      • 10.4.1.1. GCC Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.2. GCC Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.3. GCC Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.4. South Africa Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.5. South Africa Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.6. South Africa Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.7. Egypt Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.8. Egypt Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.9. Egypt Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.10. Nigeria Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.11. Nigeria Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.12. Nigeria Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.13. Rest of Middle East & Africa Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.14. Rest of Middle East & Africa Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.15. Rest of Middle East & Africa Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 10.4.2. BPS Analysis/Market Attractiveness Analysis

11. Competitive Landscape

  • 11.1. By End User vs by Source Heat map
  • 11.2. Manufacturer vs by Source Heatmap
  • 11.3. Company Market Share Analysis, 2023
  • 11.4. Competitive Dashboard
  • 11.5. Company Profiles
    • 11.5.1. Merck
      • 11.5.1.1. Company Overview
      • 11.5.1.2. Product Portfolio
      • 11.5.1.3. Financial Overview
      • 11.5.1.4. Business Strategies and Development
    • 11.5.2. Avra Synthesis Private Limited
      • 11.5.2.1. Company Overview
      • 11.5.2.2. Product Portfolio
      • 11.5.2.3. Financial Overview
      • 11.5.2.4. Business Strategies and Development
    • 11.5.3. Spectrum Chemical
      • 11.5.3.1. Company Overview
      • 11.5.3.2. Product Portfolio
      • 11.5.3.3. Financial Overview
      • 11.5.3.4. Business Strategies and Development
    • 11.5.4. Cayman Chemical Company (Matreya)
      • 11.5.4.1. Company Overview
      • 11.5.4.2. Product Portfolio
      • 11.5.4.3. Financial Overview
      • 11.5.4.4. Business Strategies and Development
    • 11.5.5. Tokyo Chemical Industry Co. Ltd.
      • 11.5.5.1. Company Overview
      • 11.5.5.2. Product Portfolio
      • 11.5.5.3. Financial Overview
      • 11.5.5.4. Business Strategies and Development
    • 11.5.6. Santa Cruz Biotechnology, Inc.
      • 11.5.6.1. Company Overview
      • 11.5.6.2. Product Portfolio
      • 11.5.6.3. Financial Overview
      • 11.5.6.4. Business Strategies and Development
    • 11.5.7. LGC Standards
      • 11.5.7.1. Company Overview
      • 11.5.7.2. Product Portfolio
      • 11.5.7.3. Financial Overview
      • 11.5.7.4. Business Strategies and Development
    • 11.5.8. Avra Synthesis Private Limited
      • 11.5.8.1. Company Overview
      • 11.5.8.2. Product Portfolio
      • 11.5.8.3. Financial Overview
      • 11.5.8.4. Business Strategies and Development
    • 11.5.9. SimSon Pharma Limited
      • 11.5.9.1. Company Overview
      • 11.5.9.2. Product Portfolio
      • 11.5.9.3. Financial Overview
      • 11.5.9.4. Business Strategies and Development
    • 11.5.10. Glentham Life
      • 11.5.10.1. Company Overview
      • 11.5.10.2. Product Portfolio
      • 11.5.10.3. Financial Overview
      • 11.5.10.4. Business Strategies and Development

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Report Assumptions
  • 12.3. Acronyms and Abbreviations